Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176791
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bruni, Laia | - |
dc.contributor.author | Saura Lázaro, Anna | - |
dc.contributor.author | Montoliu, Alexandra | - |
dc.contributor.author | Brotons, Maria | - |
dc.contributor.author | Alemany i Vilches, Laia | - |
dc.contributor.author | Diallo, Mamadou Saliou | - |
dc.contributor.author | Afsar, Oya Zeren | - |
dc.contributor.author | Lamontagne, D. Scott | - |
dc.contributor.author | Mosina, Liudmila | - |
dc.contributor.author | Contreras, Marcela | - |
dc.contributor.author | Velandia González, Martha | - |
dc.contributor.author | Pastore, Roberta | - |
dc.contributor.author | Gacic Dobo, Marta | - |
dc.contributor.author | Bloem, Paul | - |
dc.date.accessioned | 2021-04-29T13:38:46Z | - |
dc.date.available | 2021-04-29T13:38:46Z | - |
dc.date.issued | 2021-03-01 | - |
dc.identifier.uri | http://hdl.handle.net/2445/176791 | - |
dc.description.abstract | WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of their countries having already introduced respectively. A record number of introductions was observed in 2019, most of which in low- and middle- income countries (LMIC) where access has been limited. Programs had an average performance coverage of around 67% for the first dose and 53% for the final dose of HPV. LMICs performed on average better than high- income countries for the first dose, but worse for the last dose due to higher dropout. Only 5 (6%) countries achieved coverages with the final dose of more than 90%, 22 countries (21%) achieved coverages of 75% or higher while 35 (40%) had a final dose coverage of 50% or less. When expressed as world population coverage (i.e., weighted by population size), global coverage of the final HPV dose for 2019 is estimated at 15%. There is a long way to go to meet the 2030 elimination target of 90%. In the post-COVID era attention should be paid to maintain the pace of introductions, specially ensuring the most populous countries introduce, and further improving program performance globally. | - |
dc.format.extent | 12 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier B. V. | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.ypmed.2020.106399 | - |
dc.relation.ispartof | Preventive Medicine, 2021, vol. 144 | - |
dc.relation.uri | https://doi.org/10.1016/j.ypmed.2020.106399 | - |
dc.rights | cc by-nc-nd (c) Bruni et al., 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Càncer de coll uterí | - |
dc.subject.classification | Vacuna del papil·lomavirus | - |
dc.subject.other | Cervix cancer | - |
dc.subject.other | Papillomavirus vaccines | - |
dc.title | HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019 | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-04-29T09:45:41Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 33388322 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0091743520304308-main.pdf | 8.26 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License